ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced Solid Tumor|Metastatic Cancer|Solid Tumor|HER2-positive Gastric Cancer|HER2-positive Metastatic Breast Cancer
Interventions: DRUG: ACE1702|DRUG: Cyclophosphamide|DRUG: Fludarabine
Sponsor: Acepodia Biotech, Inc.